Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Activating Kras in mouse skin causes excess skin and hair loss.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Nilotinib can cause skin issues like red bumps and hair loss.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

LHX2 is essential for hair follicle development, controlled by NF-κB and TGFβ2 signaling.

High DKK1 levels predict worse survival in head and neck cancer.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Phospholipase C-δ1 is crucial for normal hair development.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Dickkopf-related Protein 2 can help hair grow by activating a specific cell pathway.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

CXCR2 in skin cells promotes tumor growth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Alk1 in specific cells is crucial for proper nerve branching and hair function.

MOF controls skin development by regulating genes for mitochondria and cilia.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

The K14 promoter is more active in skin cells than the K5 promoter.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

CDK4 levels affect the number of hair follicle stem cells in mice.